Technical Analysis:
Kaynes Technology shows strong sell signals across indicators, with RSI(14) at 23.66 (oversold), STOCHRSI at 0, and Williams %R at -98.36 indicating potential exhaustion but persistent downtrend. Stock trades below all key MAs (5-day SMA ₹5700, 20-day ₹5757, 50-day ₹5846, 200-day ₹5931), confirming bearish momentum; CCI(-196) and high ATR(46) signal volatility with support at ₹5655-5688 (pivot S3-S1) and resistance ₹5700-5723. Recent intraday low ₹4979 reflects -10.28% weekly drop vs Sensex -0.63%, with MACD bearish at -47.52.
Fundamental Analysis:
Kaynes reports robust TTM revenue ₹3225 Cr (+50.82% YoY), EBITDA ₹638 Cr (+66.94%), and net profit ₹379 Cr (+60.09%), with ROE 12.17% and net margin 11.74% showing operational strength. Growth sustained over 5 quarters with EPS ₹58.44 (+49.59% YoY), though price-to-intrinsic value at 6.25 flags overvaluation; low debt and rising assets support EMS sector expansion. Q2 FY26 earnings call held Nov 2025, with steady ROA amid capex for OSAT/semicon.
Recent Downfall Reasons:
Kaynes fell 5.91%-6.3% on Dec 4 to ₹4978-5065, extending -10.28% weekly and -24.76% monthly losses due to Kotak Equities flagging FY25 related-party disclosure mismatches (e.g., Iskraemeco ₹180 Cr unlisted) and lock-in expiry freeing 20% shares (11.6M) in Nov. Profit-taking post-Q2 results and sector underperformance amid high valuations amplified selling, diverging from Sensex gains.
Downfall Assessment and Buy Strategy:
Oversold RSI/STOCH suggest downfall pausing near ₹5000 support, but strong sell MAs and no reversal confirmation indicate caution—downtrend likely persists short-term. Short-term buy risky; accumulate long-term on dips to ₹4800-5000 if fundamentals hold, given growth trajectory—wait for pullback or ₹5700 close above for entry. Risk-averse traders should monitor for further correction to ₹4500-4700 before longing.
Upcoming Events:
Q2 FY26 results published Nov 4-5, 2025; next board meeting/analyst meets possibly Jan 2026 for Q3, with OSAT groundbreaking and Kaynes Semicon-Aptos collaboration impacting positively via revenue ramp-up late 2025. Resignation of Independent Director Anup Kumar Bhat (Nov 10) noted; monitor Q3 earnings for capex updates—potential catalyst if margins expand.
Disclaimer & Disclosure:
This analysis serves educational purposes only, not as investment advice. Past performance guarantees no future results. Consult SEBI-registered advisor prior to trading. Investogainer Research holds no position in Kaynes Technology; based on public data as of Dec 4, 2025. SEBI Registration No: INH000012345 (hypothetical). Risks include disclosure issues, volatility, and sector slowdowns.